Ulbrich K - Search Results

1

Detection and cellular localisation of the synthetic soluble macromolecular drug carrier pHPMA.

Kissel M, Peschke P, Subr V, Ulbrich K, Strunz AM, Kühnlein R, Debus J, Friedrich E. Kissel M, et al. Among authors: ulbrich k. Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1055-62. doi: 10.1007/s00259-002-0835-0. Epub 2002 May 25. Eur J Nucl Med Mol Imaging. 2002. PMID: 12173020

2

Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.

Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Debus J, Huber P, Hennink W, Storm G. Lammers T, et al. Among authors: ulbrich k. J Control Release. 2007 Feb 26;117(3):333-41. doi: 10.1016/j.jconrel.2006.10.032. Epub 2006 Nov 25. J Control Release. 2007. PMID: 17215057

3

Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.

Kissel M, Peschke P, Subr V, Ulbrich K, Schuhmacher J, Debus J, Friedrich E. Kissel M, et al. Among authors: ulbrich k. PDA J Pharm Sci Technol. 2001 May-Jun;55(3):191-201. PDA J Pharm Sci Technol. 2001. PMID: 11417110

4

Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.

Lammers T, Kühnlein R, Kissel M, Subr V, Etrych T, Pola R, Pechar M, Ulbrich K, Storm G, Huber P, Peschke P. Lammers T, et al. Among authors: ulbrich k. J Control Release. 2005 Dec 10;110(1):103-18. doi: 10.1016/j.jconrel.2005.09.010. Epub 2005 Nov 7. J Control Release. 2005. PMID: 16274831

5

Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.

Kiessling F, Heilmann M, Lammers T, Ulbrich K, Subr V, Peschke P, Waengler B, Mier W, Schrenk HH, Bock M, Schad L, Semmler W. Kiessling F, et al. Among authors: ulbrich k. Bioconjug Chem. 2006 Jan-Feb;17(1):42-51. doi: 10.1021/bc0501909. Bioconjug Chem. 2006. PMID: 16417250

6

Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.

Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Huber P, Hennink W, Storm G. Lammers T, et al. Among authors: ulbrich k. Neoplasia. 2006 Oct;8(10):788-95. doi: 10.1593/neo.06436. Neoplasia. 2006. PMID: 17032495 Free PMC article.

7

Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G. Lammers T, et al. Among authors: ulbrich k. Biomaterials. 2009 Jul;30(20):3466-75. doi: 10.1016/j.biomaterials.2009.02.040. Epub 2009 Mar 21. Biomaterials. 2009. PMID: 19304320

8

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.

Lammers T, Subr V, Peschke P, Kühnlein R, Hennink WE, Ulbrich K, Kiessling F, Heilmann M, Debus J, Huber PE, Storm G. Lammers T, et al. Among authors: ulbrich k. Br J Cancer. 2008 Sep 16;99(6):900-10. doi: 10.1038/sj.bjc.6604561. Br J Cancer. 2008. PMID: 19238631 Free PMC article.

9

Structural and chemical aspects of HPMA copolymers as drug carriers.

Ulbrich K, Subr V. Ulbrich K, et al. Adv Drug Deliv Rev. 2010 Feb 17;62(2):150-66. doi: 10.1016/j.addr.2009.10.007. Epub 2009 Nov 18. Adv Drug Deliv Rev. 2010. PMID: 19931329 Review.

10

HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F. Lammers T, et al. Among authors: ulbrich k. Nanomedicine (Lond). 2010 Dec;5(10):1501-23. doi: 10.2217/nnm.10.130. Nanomedicine (Lond). 2010. PMID: 21143030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters